论文部分内容阅读
CXCR7作为新近发现的趋化因子CXCL12的另一个受体,被证实与肿瘤的发生发展密切相关,逐渐成为了研究的热点。我们综合近年来有关该基因与肿瘤关系的研究做一综述。
As another newly discovered chemokine CXCL12 receptor, CXCR7 has been proved to be closely related to tumorigenesis and progression and has gradually become a hot research topic. We summarize recent studies on the relationship between this gene and tumor.